Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous ste... by Derman, Benjamin A., Stefka, Andrew T., Jiang, Ken, McIver, Amanda, Kubicki, Tadeusz, Jasielec, Jagoda K., Jakubowiak, Andrzej J.

Get full text

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma by Jasielec, Jagoda K., Kubicki, Tadeusz, Raje, Noopur, Vij, Ravi, Reece, Donna, Berdeja, Jesus, Derman, Benjamin A., Rosenbaum, Cara A., Richardson, Paul, Gurbuxani, Sandeep, Major, Sarah, Wolfe, Brittany, Stefka, Andrew T., Stephens, Leonor, Tinari, Kathryn M., Hycner, Tyler, Rojek, Alexandra E., Dytfeld, Dominik, Griffith, Kent A., Zimmerman, Todd M., Jakubowiak, Andrzej J.

Get full text

Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma by Jakubowiak, Andrzej J., Jasielec, Jagoda K., Rosenbaum, Cara A., Cole, Craig E., Chari, Ajai, Mikhael, Joseph, Nam, Jennifer, McIver, Amanda, Severson, Erica, Stephens, Leonor A., Tinari, Kathryn, Rosebeck, Shaun, Zimmerman, Todd M., Hycner, Tyler, Turowski, Agata, Karrison, Theodore, Zonder, Jeffrey A.

Get full text

Clinician attitudes and practices toward measurable residual disease in multiple myeloma by Derman, Benjamin A., Jasielec, Jagoda K., Jakubowiak, Andrzej J.

Get full text

Selinexor-Containing Regimens for the Treatment of Patients with Multiple Myeloma Refractory to Chimeric Antigen Receptor T-Cell (CAR-T) Therapy by Chari, Ajai, Vogl, Dan T., Jagannath, Sundar, Jasielec, Jagoda K., DeCastro, Andrew, Unger, TJ, Shah, Jatin, Jakubowiak, Andrzej

Get full text

Efficacy and Safety of Carfilzomib-Lenalidomide-Dexamethasone (KRd) in Newly Diagnosed Multiple Myeloma: Pooled Analysis of 4 Single-Arm Studies by Landgren, Ola, Attal, Michel, Kazandjian, Dickran, Roussel, Murielle, Jasielec, Jagoda K., Dytfeld, Dominik, Anderson, Aparna, Kervin, Tara, Iskander, Karim, Mezzi, Khalid, Welliver, Tim, Yusuf, Akeem, Jakubowiak, Andrzej

Get full text

Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell Therapy by Berdeja, Jesus G., Alsina, Melissa, Shah, Nina D., Siegel, David S., Jagannath, Sundar, Madduri, Deepu, Kaufman, Jonathan L., Munshi, Nikhil C., Rosenblatt, Jacalyn, Jasielec, Jagoda K., Lin, Yi, Turka, Ashley, Lam, Lyh Ping, Massaro, Monica, Campbell, Timothy B., Hege, Kristen, Petrocca, Fabio, Raje, Noopur S.

Get full text

High Rate of Sustained Minimal Residual Disease Negativity Predicts Prolonged Survival for the Overall Patient Population in the Phase 2 KRd Plus Autologous Stem Cell Transplantati... by Jakubowiak, Andrzej J., Raje, Noopur, Vij, Ravi, Reece, Donna, Berdeja, Jesus G., Stephens, Leonor, Tinari, Kathryn M., Rosenbaum, Cara A., Jasielec, Jagoda K., Richardson, Paul G, Gurbuxani, Sandeep, Nam, Jennifer, Severson, Erica, McIver, Amanda, Wolfe, Brittany, Major, Sarah, Rosebeck, Shaun, Stefka, Andrew, Johnson, David, Dytfeld, Dominik, Griffith, Kent, Turowski, Agata, Hycner, Tyler, Zimmerman, Todd M.

Get full text

Carfilzomib (CFZ, Kyprolis®), Lenalidomide (LEN, Revlimid®), and Dexamethasone (DEX) (KRd) Combined with Autologous Stem Cell Transplant (ASCT) Shows Improved Efficacy Compared wit... by Zimmerman, Todd M., MD, Griffith, Kent, Jasielec, Jagoda K, Rosenbaum, Cara A, Berdeja, Jesus G., MD, Vij, Ravi, MD, Raje, Noopur, MD, Reece, Donna E., MD, Vesole, David H., MD, PhD, Jagannath, Sundar, MD, Kaminski, Mark, Cole, Craig, Nam, Jennifer, Stephens, Leonor A, Rosebeck, Shaun, Gurbuxani, Sandeep, Dytfeld, Dominik, Jakubowiak, Andrzej J

Get full text

Management of hemophagocytic lymphohistiocytosis (HLH) associated with chimeric antigen receptor T-cell (CAR-T) therapy using anti-cytokine therapy: an illustrative case and review... by Major, Ajay, Collins, Jennifer, Craney, Caroline, Heitman, Alisa K., Bauer, Emily, Zerante, Elizabeth, Stock, Wendy, Bishop, Michael R., Jasielec, Jagoda

Get full text

Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma by Dytfeld, Dominik, Jasielec, Jagoda, Griffith, Kent A, Lebovic, Daniel, Vesole, David H, Jagannath, Sundar, Al-Zoubi, Ammar, Anderson, Tara, Detweiler-Short, Kristen, Stockerl-Goldstein, Keith, Ahmed, Asra, Jobkar, Terri, Durecki, Diane E, McDonnell, Kathryn, Mietzel, Melissa, Couriel, Daniel, Kaminski, Mark, Vij, Ravi, Jakubowiak, Andrzej J

Get full text